Exela Pharma Sciences LLC has recalled 5,256 bottles of Diclofenac Sodium and Misoprostol Delayed Release Tablets, a prescription medication used to treat arthritis symptoms and prevent stomach ulcers. The recall was issued because bottles labeled as containing 75 mg/0.2 mg tablets actually contained a lower dosage of 50 mg/0.2 mg tablets. This mix-up means patients may receive less medication than their doctor prescribed, which could lead to ineffective treatment of their condition.
A labeling error caused lower-dose 50 mg tablets to be packaged in bottles labeled as 75 mg, which could result in a patient receiving an inadequate dose of medication to manage pain and inflammation.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.